TrialJAMA oncology2017

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.

Ethan Basch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.